美敦力新一代药物洗脱支架的安全性与有效性齐国先课件.pptVIP

n/a Endeavor II (n=581/598) Sirius (n=501/525) Taxus IV (n=618/650) 关键试验的TLR: DES 组 每一年的TLR随访 5.9 6.5 7.2 7.2 R 2 = 0.9524 0 2 4 6 8 10 1 2 3 4 5 Years of Follow-up TLR (%) 4.9 6.8 7.9 9.4 6.3 R 2 = 0.9762 0 2 4 6 8 10 1 2 3 4 5 Years of Follow-up TLR (%) 4.4 5.6 6.9 7.8 9.1 R 2 = 0.9973 0 2 4 6 8 10 Years of Follow-up TLR (%) 1 2 3 4 5 4 Year Clinical Results of TAXUS IV, Stone, ACC 2006 4 year Outcomes in the Sirius Trial, Leon, TCT 2006 Endeavor II 4 year : Fajadet et al. PCR 2008 DES 研究进展 随访4 年TLR 标志性研究 Endeavor II (n=581/598) Sirius (n=501/525) Taxus IV (n=618/650) Days % TLR 4